These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 12097290)
21. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer. Hamel N; Kotar K; Foulkes WD BMC Med Genet; 2003 Aug; 4():7. PubMed ID: 12911837 [TBL] [Abstract][Full Text] [Related]
22. Germline mutations of BRCA1 and BRCA2 in Korean sporadic ovarian carcinoma. Kim YT; Nam EJ; Yoon BS; Kim SW; Kim SH; Kim JH; Kim HK; Koo JS; Kim JW Gynecol Oncol; 2005 Dec; 99(3):585-90. PubMed ID: 16084575 [TBL] [Abstract][Full Text] [Related]
23. Mutation analysis of BRCA1 and BRCA2 from 793 Korean patients with sporadic breast cancer. Han SH; Lee KR; Lee DG; Kim BY; Lee KE; Chung WS Clin Genet; 2006 Dec; 70(6):496-501. PubMed ID: 17100994 [TBL] [Abstract][Full Text] [Related]
24. RNA-based analysis of BRCA1 and BRCA2 gene alterations. Bonatti F; Pepe C; Tancredi M; Lombardi G; Aretini P; Sensi E; Falaschi E; Cipollini G; Bevilacqua G; Caligo MA Cancer Genet Cytogenet; 2006 Oct; 170(2):93-101. PubMed ID: 17011978 [TBL] [Abstract][Full Text] [Related]
25. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589 [TBL] [Abstract][Full Text] [Related]
26. Increased rates of spontaneous sister chromatid exchange in lymphocytes of BRCA2+/- carriers of familial breast cancer clusters. Kim MK; Zitzmann S; Westermann F; Arnold K; Brouwers S; Schwab M; Savelyeva L Cancer Lett; 2004 Jul; 210(1):85-94. PubMed ID: 15172125 [TBL] [Abstract][Full Text] [Related]
28. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer. Lehman TA; Haffty BG; Carbone CJ; Bishop LR; Gumbs AA; Krishnan S; Shields PG; Modali R; Turner BC Cancer Res; 2000 Feb; 60(4):1062-9. PubMed ID: 10706125 [TBL] [Abstract][Full Text] [Related]
29. BRCA1 and BRCA2 mutations in women with familial or early-onset breast/ovarian cancer in the Czech Republic. Foretova L; Machackova E; Navratilova M; Pavlu H; Hruba M; Lukesova M; Valik D Hum Mutat; 2004 Apr; 23(4):397-8. PubMed ID: 15024741 [TBL] [Abstract][Full Text] [Related]
30. Mutations in the BRCA2 gene in hepatocellular carcinomas. Katagiri T; Nakamura Y; Miki Y Cancer Res; 1996 Oct; 56(20):4575-7. PubMed ID: 8840963 [TBL] [Abstract][Full Text] [Related]
31. Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer. Patmasiriwat P; Bhothisuwan K; Sinilnikova OM; Chopin S; Methakijvaroon S; Badzioch M; Padungsutt P; Vattanaviboon P; Vattanasapt V; Szabo C; Saunders GF; Goldgar D; Lenoir GM Hum Mutat; 2002 Sep; 20(3):230. PubMed ID: 12203997 [TBL] [Abstract][Full Text] [Related]
32. Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families. Bartsch DK; Langer P; Habbe N; Matthäi E; Chaloupka B; Sina M; Hahn SA; Slater EP Clin Genet; 2010 Apr; 77(4):333-41. PubMed ID: 20041885 [TBL] [Abstract][Full Text] [Related]
33. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Tersmette AC; Petersen GM; Offerhaus GJ; Falatko FC; Brune KA; Goggins M; Rozenblum E; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH Clin Cancer Res; 2001 Mar; 7(3):738-44. PubMed ID: 11297271 [TBL] [Abstract][Full Text] [Related]
34. Rad52 gene mutations in breast/ovarian cancer families and sporadic ovarian carcinoma patients. Tong D; Volm T; Eberhardt E; Krainer M; Leodolter S; Kreienberg R; Zeillinger R Oncol Rep; 2003; 10(5):1551-3. PubMed ID: 12883740 [TBL] [Abstract][Full Text] [Related]
35. Similar contributions of BRCA1 and BRCA2 germline mutations to early-onset breast cancer in Germany. Hamann U; Liu X; Bungardt N; Ulmer HU; Bastert G; Sinn HP Eur J Hum Genet; 2003 Jun; 11(6):464-7. PubMed ID: 12774040 [TBL] [Abstract][Full Text] [Related]
36. Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2. Claes K; Poppe B; Machackova E; Coene I; Foretova L; De Paepe A; Messiaen L Genes Chromosomes Cancer; 2003 Jul; 37(3):314-20. PubMed ID: 12759930 [TBL] [Abstract][Full Text] [Related]
37. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595 [TBL] [Abstract][Full Text] [Related]
38. [Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai]. Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3030-4. PubMed ID: 16324400 [TBL] [Abstract][Full Text] [Related]
39. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors. Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267 [TBL] [Abstract][Full Text] [Related]
40. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Díez O; Osorio A; Durán M; Martinez-Ferrandis JI; de la Hoya M; Salazar R; Vega A; Campos B; Rodríguez-López R; Velasco E; Chaves J; Díaz-Rubio E; Jesús Cruz J; Torres M; Esteban E; Cervantes A; Alonso C; San Román JM; González-Sarmiento R; Miner C; Carracedo A; Eugenia Armengod M; Caldés T; Benítez J; Baiget M Hum Mutat; 2003 Oct; 22(4):301-12. PubMed ID: 12955716 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]